May
31
Main Street Family Pharmacy LLC has announced a voluntary recall of one of its pharmaceutical products. The product, an injectable anti-inflammatory drug, has been linked to seven cases of adverse events in the form of skin abscesses, one of which, the FDA reports, appears to be fungal in nature. Although the investigation into the exact source […]
May
27
GranuFlo®, along with Naturalyte®, is a component of dialysis solution used in cleaning a patient’s blood during dialysis treatment. The drug has been linked to a number of harmful side effects and injuries, including stroke, cardiac arrhythmia, and cardiac arrest. Such dangers led to a Class I Recall of the drug in 2012. As the […]
May
26
According to a recent report, research suggests that Zoloft®, a commonly prescribed selective serotonin reuptake inhibitor (SSRI), may lead to surgical complications. A study conducted by Dr. Andrew Auerbach and his team revealed that patients taking Zoloft® and other SSRIs were more likely to be readmitted to the hospital within a month of surgery. The […]
May
25
This month, two new studies evaluate the dangers of intracranial Pradaxa® brain hemorrhage among patients with closed head injuries. In the Journal of Neurosurgery report, researchers compared case studies among head trauma patients on Warfarin®, an older blood thinner, with patients on Pradaxa® and others who took no anticoagulants. The study included fifteen patients who […]
May
24
According to a report about the first Actos® lawsuit to go to trial in California, Dr. Norm Smith, a professor at the University of Chicago Medical Center, testified about the medical effects of Jack Cooper’s ingestion of Actos®. In particular, the doctor noted that Mr. Cooper had a history of cigarette smoking, including a bout […]
May
23
According to California court documents released in April, an internal evaluation by Johnson & Johnson found that nearly 40 percent of patients with a DePuy ASR™ (Articular Surface Replacement) hip system would experience total failure within five years. Most prosthetic hips, however, are engineered to last up to fifteen years, with hip replacement rates after […]
May
22
On March 29, 2013, the Judicial Panel on Multidistrict Litigation (JPML) announced that all NaturaLyte® and GranuFlo® federal lawsuits will be consolidated for pre-trial proceedings in the Northern District of Massachusetts. Fresenius Medical Care, the manufacturer of NaturaLyte® and GranuFlo®, began selling the dialysates in 2003, when they first received FDA approval. Both are engineered […]
May
21
According to a news update, Boehringer Ingelheim, the manufacturer of the anticoagulant Pradaxa®, is the target of a lawsuit over allegations that the drug leads to severe internal bleeding. One of the plaintiffs in this lawsuit – which is now part of the Pradaxa® MDL pending in the Southern District of Illinois – Robert Connelly, […]
May
20
On April 13, 2013, the Consumers’ Union sent a letter to the FDA urging it to adopt a rule that would require the agency’s premarket approval (PMA) to review high risk implants in order to determine their safety. According to the letter, which was signed by more than 11,000 people, current loopholes in the law […]
May
14
There are currently over 2,000 Actos bladder cancer claims on file against Takeda Pharmaceuticals in Cook County Circuit Court in Chicago, Illinois. As of now, the first trials for the Cook County consolidated litigation are scheduled to commence in Chicago within the next year. Actos® is a medication prescribed to control glucose (blood sugar) in […]
000-017 000-080 000-089 000-104 000-105 000-106 070-461 100-101 100-105 , 100-105 , 101 101-400 102-400 1V0-601 1Y0-201 1Z0-051 1Z0-060 1Z0-061 1Z0-144 1z0-434 1Z0-803 1Z0-804 1z0-808 200-101 200-120 200-125 , 200-125 , 200-310 200-355 210-060 210-065 210-260 220-801 220-802 220-901 220-902 2V0-620 2V0-621 2V0-621D 300-070 300-075 300-101 300-115 300-135 3002 300-206 300-208 300-209 300-320 350-001 350-018 350-029 350-030 350-050 350-060 350-080 352-001 400-051 400-101 400-201 500-260 640-692 640-911 640-916 642-732 642-999 700-501 70-177 70-178 70-243 70-246 70-270 70-346 70-347 70-410 70-411 70-412 70-413 70-417 70-461 70-462 70-463 70-480 70-483 70-486 70-487 70-488 70-532 70-533 70-534 70-980 74-678 810-403 9A0-385 9L0-012 9L0-066 ADM-201 AWS-SYSOPS C_TFIN52_66 c2010-652 c2010-657 CAP CAS-002 CCA-500 CISM CISSP CRISC EX200 EX300 HP0-S42 ICBB ICGB ITILFND JK0-022 JN0-102 JN0-360 LX0-103 LX0-104 M70-101 MB2-704 MB2-707 MB5-705 MB6-703 N10-006 NS0-157 NSE4 OG0-091 OG0-093 PEGACPBA71V1 PMP PR000041 SSCP SY0-401 VCP550
Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.
The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.
We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.
Copyright © 2013 Schlichter Bogard & Denton